Company Presentation - J.P. Morgan Healthcare ... - MorphoSys
Company Presentation - J.P. Morgan Healthcare ... - MorphoSys
Company Presentation - J.P. Morgan Healthcare ... - MorphoSys
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
A Rapidly p y Growing gClinical Pipeline p<br />
Number of Partnered & Proprietary Programs in Clinical Trials at Year-end<br />
20<br />
15<br />
10<br />
5<br />
0<br />
Corporate<br />
1<br />
2<br />
Phase 1 Phase 2<br />
1<br />
4<br />
4 4 4<br />
6<br />
10<br />
2005 2006 2007 2008 2009 2010 2011E*<br />
Clinical Antibody Pipeline is aKeyValueDriver<br />
a Key Value Driver<br />
Technology Pipeline AbD Serotec<br />
* assuming no attrition<br />
© <strong>MorphoSys</strong> AG Page 16
Change language